IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atea Pharmaceuticals Inc

CUSIP: 04653R106 | 1 institutional holders

Quarters

Q1 2021
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2021

ABG Innovation Capital Partners III GP Ltd2,639,178
80.1% of portfolio›$163.0K
StyleTurnoverLocationFiled
ABG Innovation Capital Partners III GP Ltd
2,639,178$163.0K80.1%N/AN/ACentral, Hong Kong, South Korea2021-05-17